Uptake and adherence to long-acting reversible contraception post-abortion

Contraception. 2010 Oct;82(4):345-53. doi: 10.1016/j.contraception.2010.04.021. Epub 2010 May 26.

Abstract

Background: This study aimed to increase use of long-acting reversible contraceptive (LARC) methods by women post-abortion.

Study design: Ten-week intervention at a public abortion clinic involving free access to three LARC methods (DMPA, LNG-IUS, Multiload Cu375); posters promoting LARC; updated information for clinic staff.

Outcome measures: change in the proportion of women choosing LARC prior to and during the intervention; rate of follow-up and method retention at 6 weeks and at 6 months post-abortion.

Results: Use of post-abortion LARC increased significantly from 44% at baseline (226/510) to 61% (310/510) during the intervention (p<.001). Use of LNG-IUS increased almost sixfold from 6% to 36%. Follow-up rates were 71% at 6 weeks (221/310) and 74% at 6 months (184/249). Method retention was 89% at 6 weeks (197/221) and 86% at 6 months (159/184).

Conclusion: Uptake of LARC by women post-abortion can be achieved by increasing access to these methods - by eliminating cost and raising awareness and benefits of long-acting methods among both clinicians and patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Induced* / statistics & numerical data
  • Adolescent
  • Adult
  • Contraception / economics
  • Contraception / methods
  • Contraception / statistics & numerical data*
  • Contraception Behavior
  • Contraceptive Agents, Female*
  • Contraceptives, Oral, Synthetic
  • Female
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Intrauterine Devices, Copper / statistics & numerical data*
  • Intrauterine Devices, Medicated / statistics & numerical data*
  • Levonorgestrel
  • Medroxyprogesterone Acetate
  • New Zealand
  • Pregnancy
  • Prospective Studies
  • Sex Education
  • Socioeconomic Factors
  • Young Adult

Substances

  • Contraceptive Agents, Female
  • Contraceptives, Oral, Synthetic
  • Levonorgestrel
  • Medroxyprogesterone Acetate